CMA vs CRDF
CMA (CMA) versus Cardiff Oncology Inc (CRDF) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
CRDF currently screens at market cap $238.8M.
Not investment advice. Open the CMA and CRDF stock pages for the full models.
Not investment advice.